

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.78354422 |
| 2 | modulation by symbiont of host immune response (GO:0052553) | 5.48914277 |
| 3 | positive regulation by symbiont of host defense response (GO:0052509) | 5.48914277 |
| 4 | modulation by symbiont of host defense response (GO:0052031) | 5.48914277 |
| 5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.48914277 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.48914277 |
| 7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.48914277 |
| 8 | amino sugar catabolic process (GO:0046348) | 5.35232997 |
| 9 | axon ensheathment in central nervous system (GO:0032291) | 5.31232265 |
| 10 | central nervous system myelination (GO:0022010) | 5.31232265 |
| 11 | microglial cell activation (GO:0001774) | 5.21437635 |
| 12 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.79366604 |
| 13 | neutrophil activation involved in immune response (GO:0002283) | 4.73294080 |
| 14 | macrophage activation involved in immune response (GO:0002281) | 4.55276283 |
| 15 | N-acetylneuraminate metabolic process (GO:0006054) | 4.19415741 |
| 16 | sphingolipid catabolic process (GO:0030149) | 4.03072945 |
| 17 | membrane lipid catabolic process (GO:0046466) | 3.99087099 |
| 18 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.98230964 |
| 19 | pinocytosis (GO:0006907) | 3.95184862 |
| 20 | regulation of superoxide anion generation (GO:0032928) | 3.88021170 |
| 21 | response to thyroid hormone (GO:0097066) | 3.85077649 |
| 22 | response to lipoprotein particle (GO:0055094) | 3.72381875 |
| 23 | axon ensheathment (GO:0008366) | 3.70862835 |
| 24 | ensheathment of neurons (GO:0007272) | 3.70862835 |
| 25 | positive regulation of mast cell degranulation (GO:0043306) | 3.67758626 |
| 26 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.67758626 |
| 27 | myelination (GO:0042552) | 3.66144820 |
| 28 | regulation of cholesterol esterification (GO:0010872) | 3.61221023 |
| 29 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.60051355 |
| 30 | negative regulation of interleukin-12 production (GO:0032695) | 3.56740067 |
| 31 | positive regulation of mast cell activation (GO:0033005) | 3.56119192 |
| 32 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.54907651 |
| 33 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.54773655 |
| 34 | respiratory burst (GO:0045730) | 3.54044297 |
| 35 | positive regulation of chemokine secretion (GO:0090197) | 3.53292978 |
| 36 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.51335349 |
| 37 | response to host immune response (GO:0052572) | 3.51335349 |
| 38 | amyloid precursor protein catabolic process (GO:0042987) | 3.51291780 |
| 39 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.47225004 |
| 40 | barbed-end actin filament capping (GO:0051016) | 3.46398205 |
| 41 | positive regulation of antigen processing and presentation (GO:0002579) | 3.46333371 |
| 42 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.45336248 |
| 43 | L-amino acid import (GO:0043092) | 3.44327225 |
| 44 | macrophage activation (GO:0042116) | 3.42493470 |
| 45 | import into cell (GO:0098657) | 3.41744657 |
| 46 | positive regulation of interferon-alpha production (GO:0032727) | 3.41108996 |
| 47 | neutrophil activation (GO:0042119) | 3.40001133 |
| 48 | B cell mediated immunity (GO:0019724) | 3.39501599 |
| 49 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.36518208 |
| 50 | myeloid cell activation involved in immune response (GO:0002275) | 3.34874920 |
| 51 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.31610265 |
| 52 | regulation of cholesterol storage (GO:0010885) | 3.30808859 |
| 53 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.27808681 |
| 54 | regulation of leukocyte degranulation (GO:0043300) | 3.26687416 |
| 55 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.26175443 |
| 56 | response to host (GO:0075136) | 3.26116503 |
| 57 | response to host defenses (GO:0052200) | 3.26116503 |
| 58 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.26116503 |
| 59 | regulation of interferon-alpha production (GO:0032647) | 3.23305759 |
| 60 | granulocyte activation (GO:0036230) | 3.21667913 |
| 61 | glucosamine-containing compound catabolic process (GO:1901072) | 3.20857942 |
| 62 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.19304991 |
| 63 | virion attachment to host cell (GO:0019062) | 3.14256185 |
| 64 | adhesion of symbiont to host cell (GO:0044650) | 3.14256185 |
| 65 | positive regulation of bone resorption (GO:0045780) | 3.13533800 |
| 66 | positive regulation of bone remodeling (GO:0046852) | 3.13533800 |
| 67 | leukocyte aggregation (GO:0070486) | 3.08070479 |
| 68 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.05199955 |
| 69 | activated T cell proliferation (GO:0050798) | 3.05040890 |
| 70 | phagosome maturation (GO:0090382) | 3.05020845 |
| 71 | cellular extravasation (GO:0045123) | 3.04257159 |
| 72 | negative regulation of B cell proliferation (GO:0030889) | 3.02506778 |
| 73 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.01069466 |
| 74 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.00461768 |
| 75 | amyloid precursor protein metabolic process (GO:0042982) | 2.99694012 |
| 76 | regulation of antigen processing and presentation (GO:0002577) | 2.99558692 |
| 77 | phospholipid efflux (GO:0033700) | 2.97875467 |
| 78 | pH reduction (GO:0045851) | 2.97207279 |
| 79 | phagocytosis, engulfment (GO:0006911) | 2.97142124 |
| 80 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.96960305 |
| 81 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.96960305 |
| 82 | fatty acid elongation (GO:0030497) | 2.96614810 |
| 83 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.91036784 |
| 84 | lipoxygenase pathway (GO:0019372) | 2.88573315 |
| 85 | glycosphingolipid catabolic process (GO:0046479) | 2.87493181 |
| 86 | positive regulation of B cell differentiation (GO:0045579) | 2.86512932 |
| 87 | regulation of hypersensitivity (GO:0002883) | 2.85984928 |
| 88 | lysosome organization (GO:0007040) | 2.85586328 |
| 89 | lytic vacuole organization (GO:0080171) | 2.85586328 |
| 90 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.85454192 |
| 91 | immunoglobulin mediated immune response (GO:0016064) | 2.84507744 |
| 92 | intracellular pH reduction (GO:0051452) | 2.84195486 |
| 93 | positive regulation of interleukin-17 production (GO:0032740) | 2.83048499 |
| 94 | glycosylceramide metabolic process (GO:0006677) | 2.82950865 |
| 95 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.82819631 |
| 96 | regulation of mast cell activation (GO:0033003) | 2.81865410 |
| 97 | response to cholesterol (GO:0070723) | 2.81523018 |
| 98 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.80850846 |
| 99 | pentose metabolic process (GO:0019321) | 2.80830507 |
| 100 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.80256190 |
| 101 | apoptotic cell clearance (GO:0043277) | 2.79542311 |
| 102 | keratan sulfate catabolic process (GO:0042340) | 2.78550543 |
| 103 | response to muramyl dipeptide (GO:0032495) | 2.78163449 |
| 104 | B cell receptor signaling pathway (GO:0050853) | 2.77565849 |
| 105 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.76484994 |
| 106 | plasma lipoprotein particle clearance (GO:0034381) | 2.74776243 |
| 107 | I-kappaB phosphorylation (GO:0007252) | 2.73490570 |
| 108 | amino acid import (GO:0043090) | 2.72667559 |
| 109 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.69745383 |
| 110 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.69301188 |
| 111 | regulation of chemokine secretion (GO:0090196) | 2.69239115 |
| 112 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.68948796 |
| 113 | myeloid leukocyte activation (GO:0002274) | 2.67174900 |
| 114 | purine nucleotide salvage (GO:0032261) | 2.64936264 |
| 115 | oligosaccharide catabolic process (GO:0009313) | 2.64682121 |
| 116 | myeloid dendritic cell differentiation (GO:0043011) | 2.64277162 |
| 117 | regulation of superoxide metabolic process (GO:0090322) | 2.63802911 |
| 118 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.63781318 |
| 119 | cholesterol efflux (GO:0033344) | 2.63598093 |
| 120 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.63427737 |
| 121 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.63151289 |
| 122 | response to laminar fluid shear stress (GO:0034616) | 2.61677724 |
| 123 | cortical actin cytoskeleton organization (GO:0030866) | 2.61572954 |
| 124 | positive regulation of tissue remodeling (GO:0034105) | 2.61509075 |
| 125 | creatine metabolic process (GO:0006600) | 2.61473204 |
| 126 | glycolipid catabolic process (GO:0019377) | 2.61429358 |
| 127 | plasma lipoprotein particle assembly (GO:0034377) | 2.59957523 |
| 128 | mast cell activation (GO:0045576) | 2.59116106 |
| 129 | myeloid dendritic cell activation (GO:0001773) | 2.58391193 |
| 130 | regulation of interleukin-17 production (GO:0032660) | 2.58225235 |
| 131 | myelin maintenance (GO:0043217) | 2.57884753 |
| 132 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.57715984 |
| 133 | protein maturation by protein folding (GO:0022417) | 2.57308133 |
| 134 | membrane protein intracellular domain proteolysis (GO:0031293) | 2.57122939 |
| 135 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.56606158 |
| 136 | response to peptidoglycan (GO:0032494) | 2.55726360 |
| 137 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.53815600 |
| 138 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.53815600 |
| 139 | regulation of mononuclear cell migration (GO:0071675) | 2.53537069 |
| 140 | regulation of mast cell degranulation (GO:0043304) | 2.53301956 |
| 141 | peptide catabolic process (GO:0043171) | 2.53110271 |
| 142 | macrophage differentiation (GO:0030225) | 2.52838506 |
| 143 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.52805886 |
| 144 | NADPH regeneration (GO:0006740) | 2.52591135 |
| 145 | B cell homeostasis (GO:0001782) | 2.52205675 |
| 146 | positive regulation of regulated secretory pathway (GO:1903307) | 2.51980338 |
| 147 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.51434859 |
| 148 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.50672297 |
| 149 | serine transport (GO:0032329) | 2.50241976 |
| 150 | negative regulation of granulocyte differentiation (GO:0030853) | 2.50233147 |
| 151 | monocyte chemotaxis (GO:0002548) | 2.49940781 |
| 152 | regulation of regulated secretory pathway (GO:1903305) | 2.49829846 |
| 153 | regulation of monocyte differentiation (GO:0045655) | 2.49305472 |
| 154 | pentose-phosphate shunt (GO:0006098) | 2.49079663 |
| 155 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.48522680 |
| 156 | tolerance induction (GO:0002507) | 2.48367114 |
| 157 | cortical cytoskeleton organization (GO:0030865) | 2.48023357 |
| 158 | pyrimidine-containing compound salvage (GO:0008655) | 2.47869305 |
| 159 | pyrimidine nucleoside salvage (GO:0043097) | 2.47869305 |
| 160 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 2.45585796 |
| 161 | cyclooxygenase pathway (GO:0019371) | 2.44301244 |
| 162 | positive regulation of smooth muscle cell migration (GO:0014911) | 2.43842955 |
| 163 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.43726789 |
| 164 | adhesion of symbiont to host (GO:0044406) | 2.43605719 |
| 165 | hyaluronan catabolic process (GO:0030214) | 2.42543932 |
| 166 | positive regulation of leukocyte degranulation (GO:0043302) | 2.42373876 |
| 167 | positive regulation of interferon-beta production (GO:0032728) | 2.41583589 |
| 168 | ceramide catabolic process (GO:0046514) | 2.41580138 |
| 169 | germinal center formation (GO:0002467) | 2.41232320 |
| 170 | regulation of macrophage chemotaxis (GO:0010758) | 2.41187657 |
| 171 | protein-lipid complex assembly (GO:0065005) | 2.40902350 |
| 172 | regulation of B cell differentiation (GO:0045577) | 2.40354222 |
| 173 | transferrin transport (GO:0033572) | 2.39868677 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.30401259 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.06140673 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.78241148 |
| 4 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.25299637 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.21790759 |
| 6 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.74798756 |
| 7 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 3.29672662 |
| 8 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.19796608 |
| 9 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.02062039 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.71321191 |
| 11 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.67989343 |
| 12 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.59946113 |
| 13 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.59299145 |
| 14 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.54358035 |
| 15 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.51449562 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.50437306 |
| 17 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.25741738 |
| 18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.14890903 |
| 19 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.14534456 |
| 20 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.12827949 |
| 21 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.11529289 |
| 22 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.09273212 |
| 23 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.06528362 |
| 24 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.99754040 |
| 25 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.98685708 |
| 26 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.97171161 |
| 27 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.96972494 |
| 28 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.96311577 |
| 29 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.95923830 |
| 30 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.91740899 |
| 31 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.90722917 |
| 32 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.83134331 |
| 33 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.77319995 |
| 34 | SPI1_23127762_ChIP-Seq_K562_Human | 1.73582813 |
| 35 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.72825579 |
| 36 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.72334924 |
| 37 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.72024497 |
| 38 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.70223333 |
| 39 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.69951600 |
| 40 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.69587957 |
| 41 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.69070635 |
| 42 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.68547592 |
| 43 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.67586732 |
| 44 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.63404553 |
| 45 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.61832524 |
| 46 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.58740030 |
| 47 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.57260932 |
| 48 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.56171929 |
| 49 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.55916114 |
| 50 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.55266666 |
| 51 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.54870018 |
| 52 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.54638020 |
| 53 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50886095 |
| 54 | MYB_26560356_Chip-Seq_TH2_Human | 1.50124167 |
| 55 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.47310883 |
| 56 | MYC_22102868_ChIP-Seq_BL_Human | 1.46317896 |
| 57 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.42359047 |
| 58 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.40907706 |
| 59 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.40429955 |
| 60 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.40263933 |
| 61 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.39972006 |
| 62 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.37288957 |
| 63 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35806683 |
| 64 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.34500684 |
| 65 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.32245093 |
| 66 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.31251658 |
| 67 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.30256916 |
| 68 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.30085207 |
| 69 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.29430181 |
| 70 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.29031043 |
| 71 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.28316634 |
| 72 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.27507834 |
| 73 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.24834710 |
| 74 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.24276481 |
| 75 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.24178711 |
| 76 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.24162595 |
| 77 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23799305 |
| 78 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.23652041 |
| 79 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.23142758 |
| 80 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.21689100 |
| 81 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.21021918 |
| 82 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.20298190 |
| 83 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.20098371 |
| 84 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.19892415 |
| 85 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.19500370 |
| 86 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.19425644 |
| 87 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.18893935 |
| 88 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.17096833 |
| 89 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.17062708 |
| 90 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.16729214 |
| 91 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.16724907 |
| 92 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16670001 |
| 93 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.15811428 |
| 94 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.15669250 |
| 95 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15605354 |
| 96 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.14544674 |
| 97 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.14355866 |
| 98 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14013365 |
| 99 | MAF_26560356_Chip-Seq_TH1_Human | 1.13710218 |
| 100 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.13559498 |
| 101 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.13302194 |
| 102 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.13280637 |
| 103 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.12795183 |
| 104 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.12754711 |
| 105 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.11757774 |
| 106 | MYB_26560356_Chip-Seq_TH1_Human | 1.11256798 |
| 107 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.09978369 |
| 108 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.09716011 |
| 109 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.08435249 |
| 110 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.08126268 |
| 111 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08112561 |
| 112 | * CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.06533904 |
| 113 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.05201687 |
| 114 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.05130916 |
| 115 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04999215 |
| 116 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.04805720 |
| 117 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.04770570 |
| 118 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.04752597 |
| 119 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.04568448 |
| 120 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.03880101 |
| 121 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.02486309 |
| 122 | GATA3_26560356_Chip-Seq_TH2_Human | 1.02238910 |
| 123 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.01496005 |
| 124 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.00998269 |
| 125 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.00942289 |
| 126 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.00649918 |
| 127 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.00601006 |
| 128 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.00525489 |
| 129 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.00324112 |
| 130 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.99808724 |
| 131 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.97156909 |
| 132 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.97156909 |
| 133 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.97109732 |
| 134 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.96382279 |
| 135 | GATA2_19941826_ChIP-Seq_K562_Human | 0.96327398 |
| 136 | GATA1_19941826_ChIP-Seq_K562_Human | 0.95228636 |
| 137 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.94635951 |
| 138 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91198667 |
| 139 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.88375265 |
| 140 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.86750664 |
| 141 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85636179 |
| 142 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.85506742 |
| 143 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.84953826 |
| 144 | TP53_16413492_ChIP-PET_HCT116_Human | 0.84295243 |
| 145 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.84123011 |
| 146 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.82306535 |
| 147 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.82153196 |
| 148 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.80743035 |
| 149 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.80524978 |
| 150 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.80085769 |
| 151 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.79467313 |
| 152 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.77597009 |
| 153 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.75950172 |
| 154 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.75477605 |
| 155 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.75226485 |
| 156 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.74619169 |
| 157 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.74186468 |
| 158 | UTX_26944678_Chip-Seq_JUKART_Human | 0.73917175 |
| 159 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.73185290 |
| 160 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.73127481 |
| 161 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.72698835 |
| 162 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.72290725 |
| 163 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.71548841 |
| 164 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.71452987 |
| 165 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.70902848 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 4.45065799 |
| 2 | MP0006082_CNS_inflammation | 3.83275336 |
| 3 | MP0000920_abnormal_myelination | 3.56084021 |
| 4 | MP0002139_abnormal_hepatobiliary_system | 3.42995924 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 3.40205800 |
| 6 | MP0001835_abnormal_antigen_presentation | 3.35351129 |
| 7 | MP0003690_abnormal_glial_cell | 3.31933229 |
| 8 | MP0005671_abnormal_response_to | 2.92455409 |
| 9 | MP0003172_abnormal_lysosome_physiology | 2.87632728 |
| 10 | MP0002419_abnormal_innate_immunity | 2.75466269 |
| 11 | MP0003191_abnormal_cellular_cholesterol | 2.70372142 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.60851733 |
| 13 | MP0003303_peritoneal_inflammation | 2.57271333 |
| 14 | MP0003436_decreased_susceptibility_to | 2.51359663 |
| 15 | MP0002148_abnormal_hypersensitivity_rea | 2.50891138 |
| 16 | MP0001790_abnormal_immune_system | 2.43281534 |
| 17 | MP0005387_immune_system_phenotype | 2.43281534 |
| 18 | MP0002452_abnormal_antigen_presenting | 2.37609578 |
| 19 | MP0001851_eye_inflammation | 2.27422495 |
| 20 | MP0001800_abnormal_humoral_immune | 2.22302222 |
| 21 | MP0002723_abnormal_immune_serum | 2.19461416 |
| 22 | MP0005365_abnormal_bile_salt | 2.19243043 |
| 23 | MP0005025_abnormal_response_to | 2.16097159 |
| 24 | MP0001819_abnormal_immune_cell | 1.94691987 |
| 25 | MP0000685_abnormal_immune_system | 1.94287793 |
| 26 | MP0002420_abnormal_adaptive_immunity | 1.94005494 |
| 27 | MP0005464_abnormal_platelet_physiology | 1.93133845 |
| 28 | MP0001533_abnormal_skeleton_physiology | 1.91873091 |
| 29 | MP0003300_gastrointestinal_ulcer | 1.83168563 |
| 30 | MP0003950_abnormal_plasma_membrane | 1.82425521 |
| 31 | MP0005310_abnormal_salivary_gland | 1.81741880 |
| 32 | MP0003724_increased_susceptibility_to | 1.76359165 |
| 33 | MP0009840_abnormal_foam_cell | 1.75661693 |
| 34 | MP0009785_altered_susceptibility_to | 1.73989678 |
| 35 | MP0002933_joint_inflammation | 1.72819690 |
| 36 | MP0002998_abnormal_bone_remodeling | 1.69578189 |
| 37 | MP0003075_altered_response_to | 1.60130664 |
| 38 | MP0000604_amyloidosis | 1.53766607 |
| 39 | MP0003634_abnormal_glial_cell | 1.53722938 |
| 40 | MP0002405_respiratory_system_inflammati | 1.52406096 |
| 41 | MP0002396_abnormal_hematopoietic_system | 1.49655281 |
| 42 | MP0000465_gastrointestinal_hemorrhage | 1.47739391 |
| 43 | MP0000716_abnormal_immune_system | 1.47472220 |
| 44 | MP0004510_myositis | 1.44531573 |
| 45 | MP0000858_altered_metastatic_potential | 1.42959053 |
| 46 | MP0003186_abnormal_redox_activity | 1.41681922 |
| 47 | MP0000343_altered_response_to | 1.41627967 |
| 48 | MP0001845_abnormal_inflammatory_respons | 1.41461161 |
| 49 | MP0004947_skin_inflammation | 1.39635003 |
| 50 | MP0008438_abnormal_cutaneous_collagen | 1.38103677 |
| 51 | MP0005397_hematopoietic_system_phenotyp | 1.37458161 |
| 52 | MP0001545_abnormal_hematopoietic_system | 1.37458161 |
| 53 | MP0001853_heart_inflammation | 1.32924924 |
| 54 | MP0004742_abnormal_vestibular_system | 1.27796082 |
| 55 | MP0009333_abnormal_splenocyte_physiolog | 1.24822083 |
| 56 | MP0002398_abnormal_bone_marrow | 1.22778555 |
| 57 | MP0008875_abnormal_xenobiotic_pharmacok | 1.22430568 |
| 58 | MP0000689_abnormal_spleen_morphology | 1.19801283 |
| 59 | MP0004019_abnormal_vitamin_homeostasis | 1.19746923 |
| 60 | MP0008469_abnormal_protein_level | 1.17535523 |
| 61 | MP0004185_abnormal_adipocyte_glucose | 1.15619193 |
| 62 | MP0003045_fibrosis | 1.14049857 |
| 63 | MP0005257_abnormal_intraocular_pressure | 1.13493343 |
| 64 | MP0005451_abnormal_body_composition | 1.12817129 |
| 65 | MP0005319_abnormal_enzyme/_coenzyme | 1.10200438 |
| 66 | MP0001764_abnormal_homeostasis | 1.09379698 |
| 67 | MP0002429_abnormal_blood_cell | 1.08946704 |
| 68 | MP0003448_altered_tumor_morphology | 1.08370279 |
| 69 | MP0000383_abnormal_hair_follicle | 1.06931694 |
| 70 | MP0004885_abnormal_endolymph | 1.06705541 |
| 71 | MP0003656_abnormal_erythrocyte_physiolo | 1.06698667 |
| 72 | MP0001958_emphysema | 1.04244806 |
| 73 | MP0010155_abnormal_intestine_physiology | 1.03793192 |
| 74 | MP0001849_ear_inflammation | 1.03261205 |
| 75 | MP0001873_stomach_inflammation | 1.01563973 |
| 76 | MP0003136_yellow_coat_color | 1.00528414 |
| 77 | MP0005390_skeleton_phenotype | 0.99613421 |
| 78 | MP0005166_decreased_susceptibility_to | 0.99476418 |
| 79 | MP0002722_abnormal_immune_system | 0.99449040 |
| 80 | MP0002166_altered_tumor_susceptibility | 0.97939179 |
| 81 | MP0003183_abnormal_peptide_metabolism | 0.96919705 |
| 82 | MP0009278_abnormal_bone_marrow | 0.93709323 |
| 83 | MP0003195_calcinosis | 0.91282870 |
| 84 | MP0002090_abnormal_vision | 0.91272941 |
| 85 | MP0005647_abnormal_sex_gland | 0.91068248 |
| 86 | MP0000609_abnormal_liver_physiology | 0.89099185 |
| 87 | MP0000371_diluted_coat_color | 0.88974235 |
| 88 | MP0000569_abnormal_digit_pigmentation | 0.88251393 |
| 89 | MP0010678_abnormal_skin_adnexa | 0.87699802 |
| 90 | MP0003795_abnormal_bone_structure | 0.86572760 |
| 91 | MP0000490_abnormal_crypts_of | 0.86284316 |
| 92 | MP0006054_spinal_hemorrhage | 0.84824610 |
| 93 | MP0002136_abnormal_kidney_physiology | 0.84271094 |
| 94 | MP0006036_abnormal_mitochondrial_physio | 0.84140313 |
| 95 | MP0005409_darkened_coat_color | 0.84054696 |
| 96 | MP0004233_abnormal_muscle_weight | 0.83856556 |
| 97 | MP0005171_absent_coat_pigmentation | 0.83814798 |
| 98 | MP0002132_abnormal_respiratory_system | 0.83690444 |
| 99 | MP0002254_reproductive_system_inflammat | 0.83478326 |
| 100 | MP0002877_abnormal_melanocyte_morpholog | 0.83176592 |
| 101 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.82742017 |
| 102 | MP0005377_hearing/vestibular/ear_phenot | 0.80520978 |
| 103 | MP0003878_abnormal_ear_physiology | 0.80520978 |
| 104 | MP0005167_abnormal_blood-brain_barrier | 0.79453504 |
| 105 | MP0008004_abnormal_stomach_pH | 0.78647736 |
| 106 | MP0005164_abnormal_response_to | 0.78561002 |
| 107 | MP0009764_decreased_sensitivity_to | 0.77744229 |
| 108 | MP0003453_abnormal_keratinocyte_physiol | 0.77726760 |
| 109 | MP0010307_abnormal_tumor_latency | 0.76715127 |
| 110 | MP0000767_abnormal_smooth_muscle | 0.75601773 |
| 111 | MP0009763_increased_sensitivity_to | 0.75475786 |
| 112 | MP0003633_abnormal_nervous_system | 0.75325032 |
| 113 | MP0005085_abnormal_gallbladder_physiolo | 0.74486861 |
| 114 | MP0000249_abnormal_blood_vessel | 0.74467671 |
| 115 | MP0003279_aneurysm | 0.72571973 |
| 116 | MP0002006_tumorigenesis | 0.72272352 |
| 117 | MP0003329_amyloid_beta_deposits | 0.72248701 |
| 118 | MP0002277_abnormal_respiratory_mucosa | 0.71930375 |
| 119 | MP0003828_pulmonary_edema | 0.71910677 |
| 120 | MP0000681_abnormal_thyroid_gland | 0.71870982 |
| 121 | MP0001666_abnormal_nutrient_absorption | 0.70956547 |
| 122 | MP0005174_abnormal_tail_pigmentation | 0.70396212 |
| 123 | MP0003693_abnormal_embryo_hatching | 0.70178219 |
| 124 | MP0003718_maternal_effect | 0.70146485 |
| 125 | MP0004134_abnormal_chest_morphology | 0.70016229 |
| 126 | MP0003091_abnormal_cell_migration | 0.69672738 |
| 127 | MP0005360_urolithiasis | 0.68483474 |
| 128 | MP0008260_abnormal_autophagy | 0.68310173 |
| 129 | MP0010329_abnormal_lipoprotein_level | 0.67082754 |
| 130 | MP0000733_abnormal_muscle_development | 0.66655224 |
| 131 | MP0000358_abnormal_cell_content/ | 0.65703991 |
| 132 | MP0005666_abnormal_adipose_tissue | 0.65571138 |
| 133 | MP0005165_increased_susceptibility_to | 0.65437600 |
| 134 | MP0003632_abnormal_nervous_system | 0.65411142 |
| 135 | MP0004381_abnormal_hair_follicle | 0.65046334 |
| 136 | MP0000313_abnormal_cell_death | 0.64220112 |
| 137 | MP0002229_neurodegeneration | 0.63685746 |
| 138 | MP0002168_other_aberrant_phenotype | 0.62699319 |
| 139 | MP0005410_abnormal_fertilization | 0.62269403 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased cerebral lipofuscin (HP:0011813) | 5.48670668 |
| 2 | Recurrent abscess formation (HP:0002722) | 5.42310436 |
| 3 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 5.25346179 |
| 4 | Systemic lupus erythematosus (HP:0002725) | 5.08382280 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 5.05501675 |
| 6 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.05007886 |
| 7 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.05007886 |
| 8 | Abnormality of glycolipid metabolism (HP:0010969) | 5.05007886 |
| 9 | Vacuolated lymphocytes (HP:0001922) | 5.02869972 |
| 10 | Eczematoid dermatitis (HP:0000976) | 4.58375819 |
| 11 | Abnormality of macrophages (HP:0004311) | 4.44236662 |
| 12 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 4.42723724 |
| 13 | Axonal loss (HP:0003447) | 4.16310460 |
| 14 | Dysostosis multiplex (HP:0000943) | 4.05480728 |
| 15 | Neurofibrillary tangles (HP:0002185) | 3.95886966 |
| 16 | Glomerulonephritis (HP:0000099) | 3.75802479 |
| 17 | Recurrent skin infections (HP:0001581) | 3.63541916 |
| 18 | Petechiae (HP:0000967) | 3.60705432 |
| 19 | Disinhibition (HP:0000734) | 3.53719440 |
| 20 | Arterial tortuosity (HP:0005116) | 3.44307071 |
| 21 | Hepatosplenomegaly (HP:0001433) | 3.33238580 |
| 22 | Vascular tortuosity (HP:0004948) | 3.03067108 |
| 23 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.02898750 |
| 24 | Loss of speech (HP:0002371) | 2.98864919 |
| 25 | Multiple enchondromatosis (HP:0005701) | 2.98168551 |
| 26 | Diminished motivation (HP:0000745) | 2.93931039 |
| 27 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.92392844 |
| 28 | Mucopolysacchariduria (HP:0008155) | 2.92392844 |
| 29 | Upper motor neuron abnormality (HP:0002127) | 2.89004028 |
| 30 | Apathy (HP:0000741) | 2.85848362 |
| 31 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.84404500 |
| 32 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.84404500 |
| 33 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.84404500 |
| 34 | Increased serum ferritin (HP:0003281) | 2.71478871 |
| 35 | Recurrent fungal infections (HP:0002841) | 2.71408002 |
| 36 | Obstructive lung disease (HP:0006536) | 2.69871185 |
| 37 | Chronic obstructive pulmonary disease (HP:0006510) | 2.69871185 |
| 38 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.67106652 |
| 39 | Peripheral demyelination (HP:0011096) | 2.61219482 |
| 40 | Autoimmune thrombocytopenia (HP:0001973) | 2.60569065 |
| 41 | Disproportionate tall stature (HP:0001519) | 2.60306171 |
| 42 | Cerebral inclusion bodies (HP:0100314) | 2.58825222 |
| 43 | Metabolic alkalosis (HP:0200114) | 2.57683581 |
| 44 | Thick nail (HP:0001805) | 2.56953102 |
| 45 | Chronic diarrhea (HP:0002028) | 2.56304591 |
| 46 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.54647975 |
| 47 | Osteolytic defects of the hand bones (HP:0009699) | 2.54647975 |
| 48 | Hypertensive crisis (HP:0100735) | 2.52721649 |
| 49 | Nuclear cataract (HP:0100018) | 2.52230035 |
| 50 | Clumsiness (HP:0002312) | 2.51717445 |
| 51 | Stomatitis (HP:0010280) | 2.51319251 |
| 52 | Cellulitis (HP:0100658) | 2.48948147 |
| 53 | Progressive neurologic deterioration (HP:0002344) | 2.47313818 |
| 54 | Hematochezia (HP:0002573) | 2.43859307 |
| 55 | Parakeratosis (HP:0001036) | 2.43639612 |
| 56 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.43507357 |
| 57 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.43507357 |
| 58 | Peripheral hypomyelination (HP:0007182) | 2.42891905 |
| 59 | Personality changes (HP:0000751) | 2.41039710 |
| 60 | Gastrointestinal stroma tumor (HP:0100723) | 2.40552167 |
| 61 | Prolonged neonatal jaundice (HP:0006579) | 2.39625272 |
| 62 | Metaphyseal irregularity (HP:0003025) | 2.39235272 |
| 63 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.38431244 |
| 64 | Recurrent viral infections (HP:0004429) | 2.36753546 |
| 65 | Mutism (HP:0002300) | 2.35385197 |
| 66 | Neuronal loss in central nervous system (HP:0002529) | 2.35104794 |
| 67 | Chronic otitis media (HP:0000389) | 2.34858622 |
| 68 | Recurrent pneumonia (HP:0006532) | 2.33705496 |
| 69 | Supranuclear gaze palsy (HP:0000605) | 2.32373224 |
| 70 | Thoracic kyphosis (HP:0002942) | 2.31409534 |
| 71 | Premature skin wrinkling (HP:0100678) | 2.29904863 |
| 72 | Progressive visual loss (HP:0000529) | 2.27821793 |
| 73 | Slow saccadic eye movements (HP:0000514) | 2.26873145 |
| 74 | Increased circulating renin level (HP:0000848) | 2.24363066 |
| 75 | Retinal atrophy (HP:0001105) | 2.22514543 |
| 76 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.22105766 |
| 77 | Pathologic fracture (HP:0002756) | 2.21678336 |
| 78 | Vertebral compression fractures (HP:0002953) | 2.20656524 |
| 79 | Colitis (HP:0002583) | 2.19619557 |
| 80 | Onion bulb formation (HP:0003383) | 2.18396753 |
| 81 | Increased IgM level (HP:0003496) | 2.17904055 |
| 82 | Spondylolisthesis (HP:0003302) | 2.17132747 |
| 83 | Gingivitis (HP:0000230) | 2.16920200 |
| 84 | Interstitial pulmonary disease (HP:0006530) | 2.16538898 |
| 85 | Recurrent cutaneous fungal infections (HP:0011370) | 2.15188079 |
| 86 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.15188079 |
| 87 | Nausea (HP:0002018) | 2.14346260 |
| 88 | Mediastinal lymphadenopathy (HP:0100721) | 2.14032664 |
| 89 | Inflammation of the large intestine (HP:0002037) | 2.11744961 |
| 90 | Eosinophilia (HP:0001880) | 2.09567650 |
| 91 | Prostate neoplasm (HP:0100787) | 2.08863010 |
| 92 | Cerebral aneurysm (HP:0004944) | 2.08828692 |
| 93 | Pustule (HP:0200039) | 2.07989784 |
| 94 | Xanthomatosis (HP:0000991) | 2.03878118 |
| 95 | Abnormality of iron homeostasis (HP:0011031) | 2.02899744 |
| 96 | Agnosia (HP:0010524) | 2.00922644 |
| 97 | * Cardiomegaly (HP:0001640) | 2.00370903 |
| 98 | Nephritis (HP:0000123) | 1.99404487 |
| 99 | Vasculitis (HP:0002633) | 1.99227847 |
| 100 | Hypokalemic alkalosis (HP:0001949) | 1.98230469 |
| 101 | Aortic aneurysm (HP:0004942) | 1.96674411 |
| 102 | Dementia (HP:0000726) | 1.96409642 |
| 103 | Leukocytosis (HP:0001974) | 1.95484918 |
| 104 | Spontaneous hematomas (HP:0007420) | 1.94571779 |
| 105 | Inappropriate behavior (HP:0000719) | 1.94442141 |
| 106 | Myocardial infarction (HP:0001658) | 1.91576832 |
| 107 | Myositis (HP:0100614) | 1.91494654 |
| 108 | Osteomyelitis (HP:0002754) | 1.90971697 |
| 109 | Gingival bleeding (HP:0000225) | 1.90714879 |
| 110 | Aortic dissection (HP:0002647) | 1.90652320 |
| 111 | Hypokinesia (HP:0002375) | 1.89247579 |
| 112 | Gastrointestinal inflammation (HP:0004386) | 1.86681356 |
| 113 | Hypomagnesemia (HP:0002917) | 1.86449884 |
| 114 | Bone pain (HP:0002653) | 1.85144594 |
| 115 | Purpura (HP:0000979) | 1.85016807 |
| 116 | Thyroiditis (HP:0100646) | 1.84814199 |
| 117 | Sensory axonal neuropathy (HP:0003390) | 1.83460983 |
| 118 | Complement deficiency (HP:0004431) | 1.82797176 |
| 119 | Amyloidosis (HP:0011034) | 1.81952670 |
| 120 | Persistence of primary teeth (HP:0006335) | 1.81690799 |
| 121 | Abnormality of eosinophils (HP:0001879) | 1.81009112 |
| 122 | Abnormal drinking behavior (HP:0030082) | 1.80221805 |
| 123 | Polydipsia (HP:0001959) | 1.80221805 |
| 124 | Basal ganglia calcification (HP:0002135) | 1.79969955 |
| 125 | Generalized aminoaciduria (HP:0002909) | 1.79799164 |
| 126 | Recurrent lower respiratory tract infections (HP:0002783) | 1.79194550 |
| 127 | Beaking of vertebral bodies (HP:0004568) | 1.78738221 |
| 128 | J-shaped sella turcica (HP:0002680) | 1.78611656 |
| 129 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.78266845 |
| 130 | Abnormality of the prostate (HP:0008775) | 1.77370511 |
| 131 | Abnormality of the periventricular white matter (HP:0002518) | 1.76814084 |
| 132 | Seborrheic dermatitis (HP:0001051) | 1.72705376 |
| 133 | Abnormality of the lumbar spine (HP:0100712) | 1.72591055 |
| 134 | Type I transferrin isoform profile (HP:0003642) | 1.70929939 |
| 135 | Ragged-red muscle fibers (HP:0003200) | 1.70266472 |
| 136 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.69501730 |
| 137 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.69033292 |
| 138 | Epistaxis (HP:0000421) | 1.68774983 |
| 139 | Esophageal neoplasm (HP:0100751) | 1.67902515 |
| 140 | Neoplasm of head and neck (HP:0012288) | 1.67902515 |
| 141 | Delusions (HP:0000746) | 1.67246460 |
| 142 | Amaurosis fugax (HP:0100576) | 1.65717998 |
| 143 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.64107237 |
| 144 | Urticaria (HP:0001025) | 1.63237142 |
| 145 | Paralysis (HP:0003470) | 1.60923245 |
| 146 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.60008907 |
| 147 | Abnormality of complement system (HP:0005339) | 1.59647702 |
| 148 | Abnormality of the thoracic spine (HP:0100711) | 1.59592310 |
| 149 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.59100014 |
| 150 | Premature loss of primary teeth (HP:0006323) | 1.58883961 |
| 151 | * Splenomegaly (HP:0001744) | 1.56968422 |
| 152 | Myoclonus (HP:0001336) | 1.55614509 |
| 153 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.54685319 |
| 154 | Protuberant abdomen (HP:0001538) | 1.54561040 |
| 155 | Opisthotonus (HP:0002179) | 1.53672010 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 5.39860214 |
| 2 | TGFBR2 | 4.57636678 |
| 3 | STK39 | 3.77200872 |
| 4 | EPHB1 | 3.76157518 |
| 5 | OXSR1 | 3.07596918 |
| 6 | TESK2 | 2.87877402 |
| 7 | PDK2 | 2.57386396 |
| 8 | CSF1R | 2.49268740 |
| 9 | VRK2 | 2.44648624 |
| 10 | GRK7 | 2.25127066 |
| 11 | TRIM28 | 2.22186140 |
| 12 | TESK1 | 2.20222747 |
| 13 | BLK | 2.19994678 |
| 14 | MAPK15 | 2.18465934 |
| 15 | MAP4K1 | 2.16638935 |
| 16 | IRAK4 | 2.11732313 |
| 17 | MAP3K14 | 2.09569459 |
| 18 | ABL2 | 2.05773586 |
| 19 | CLK1 | 2.03553405 |
| 20 | TYK2 | 2.01372132 |
| 21 | MAP3K11 | 1.96135128 |
| 22 | TAOK2 | 1.94304228 |
| 23 | KIT | 1.92343234 |
| 24 | ITK | 1.88921025 |
| 25 | IRAK3 | 1.82908865 |
| 26 | BCKDK | 1.77791252 |
| 27 | CAMK1D | 1.73809534 |
| 28 | STK10 | 1.71904555 |
| 29 | RIPK4 | 1.69766533 |
| 30 | CAMK1G | 1.68773814 |
| 31 | PBK | 1.68529659 |
| 32 | PIM2 | 1.67927533 |
| 33 | TBK1 | 1.67631751 |
| 34 | IKBKB | 1.64016236 |
| 35 | PKN1 | 1.60507697 |
| 36 | MAP3K3 | 1.54579411 |
| 37 | MST4 | 1.53813306 |
| 38 | WNK1 | 1.52676596 |
| 39 | WNK4 | 1.47677600 |
| 40 | FGR | 1.47497176 |
| 41 | BUB1 | 1.47141265 |
| 42 | JAK1 | 1.43110978 |
| 43 | EIF2AK1 | 1.41538519 |
| 44 | CSK | 1.38329600 |
| 45 | MUSK | 1.33959002 |
| 46 | HCK | 1.30240708 |
| 47 | TEC | 1.25837914 |
| 48 | STK16 | 1.25006584 |
| 49 | TAOK1 | 1.23714386 |
| 50 | LIMK1 | 1.23541441 |
| 51 | MAP2K3 | 1.22987044 |
| 52 | SMG1 | 1.22805139 |
| 53 | MAP3K13 | 1.19942087 |
| 54 | LCK | 1.18278096 |
| 55 | TXK | 1.18021750 |
| 56 | TRPM7 | 1.16983019 |
| 57 | ZAP70 | 1.15593551 |
| 58 | IKBKE | 1.14583751 |
| 59 | MAPKAPK5 | 1.12161497 |
| 60 | GRK6 | 1.09006830 |
| 61 | LYN | 1.08317239 |
| 62 | BTK | 1.08082911 |
| 63 | JAK3 | 1.07159369 |
| 64 | DAPK1 | 1.06914474 |
| 65 | ICK | 1.06896928 |
| 66 | MAP3K1 | 1.06813169 |
| 67 | CDK12 | 1.04293980 |
| 68 | KDR | 1.02719601 |
| 69 | MET | 1.02011141 |
| 70 | SIK3 | 1.00639906 |
| 71 | CSNK1A1L | 0.94184093 |
| 72 | ADRBK2 | 0.92741129 |
| 73 | EPHA2 | 0.91946825 |
| 74 | ARAF | 0.91293331 |
| 75 | FGFR2 | 0.86901181 |
| 76 | SYK | 0.82349176 |
| 77 | ERN1 | 0.82183816 |
| 78 | MATK | 0.79096605 |
| 79 | PRKCQ | 0.78396729 |
| 80 | MAP3K8 | 0.76649154 |
| 81 | FES | 0.75118416 |
| 82 | CAMKK2 | 0.72308215 |
| 83 | IRAK2 | 0.71329840 |
| 84 | IRAK1 | 0.71111152 |
| 85 | MARK3 | 0.70453437 |
| 86 | DDR2 | 0.70107940 |
| 87 | CHUK | 0.67712777 |
| 88 | NEK6 | 0.66869830 |
| 89 | CSNK1G3 | 0.66515576 |
| 90 | ROCK2 | 0.64094151 |
| 91 | PDPK1 | 0.63485193 |
| 92 | CDC42BPA | 0.63239951 |
| 93 | PDGFRB | 0.62937319 |
| 94 | CSNK1G1 | 0.61206033 |
| 95 | EGFR | 0.60932957 |
| 96 | BMX | 0.60663423 |
| 97 | MAP3K5 | 0.59904963 |
| 98 | ACVR1B | 0.59300734 |
| 99 | MAPKAPK2 | 0.59281122 |
| 100 | PRPF4B | 0.59126020 |
| 101 | MAPK7 | 0.58746020 |
| 102 | ABL1 | 0.57943481 |
| 103 | TNIK | 0.57448619 |
| 104 | PRKD1 | 0.56463625 |
| 105 | BMPR1B | 0.55789392 |
| 106 | CDK19 | 0.55645437 |
| 107 | MAP3K12 | 0.55027962 |
| 108 | JAK2 | 0.54878147 |
| 109 | EPHA3 | 0.53621316 |
| 110 | MAPK12 | 0.53250511 |
| 111 | TAOK3 | 0.53155847 |
| 112 | STK4 | 0.53010722 |
| 113 | PDK1 | 0.52763392 |
| 114 | TNK2 | 0.52652812 |
| 115 | FYN | 0.52585015 |
| 116 | BRD4 | 0.52312713 |
| 117 | GSK3A | 0.50900775 |
| 118 | PAK2 | 0.50626284 |
| 119 | NME1 | 0.49911350 |
| 120 | INSR | 0.49693352 |
| 121 | SIK1 | 0.49574899 |
| 122 | RPS6KA5 | 0.49385310 |
| 123 | DAPK3 | 0.49287694 |
| 124 | NEK9 | 0.49145216 |
| 125 | CDK9 | 0.45142587 |
| 126 | NUAK1 | 0.44947595 |
| 127 | VRK1 | 0.42801045 |
| 128 | PAK1 | 0.42592866 |
| 129 | IGF1R | 0.42351028 |
| 130 | YES1 | 0.42330571 |
| 131 | LRRK2 | 0.41658823 |
| 132 | MOS | 0.41360870 |
| 133 | DMPK | 0.40135531 |
| 134 | PAK4 | 0.39700333 |
| 135 | PRKCD | 0.39014824 |
| 136 | CDK6 | 0.38233409 |
| 137 | BMPR2 | 0.36486751 |
| 138 | CDK7 | 0.36467314 |
| 139 | PRKAA2 | 0.35155622 |
| 140 | MELK | 0.34380520 |
| 141 | CSNK2A1 | 0.34364288 |
| 142 | CAMK2G | 0.34304422 |
| 143 | STK3 | 0.34020317 |
| 144 | CDK3 | 0.33853038 |
| 145 | FGFR4 | 0.33768129 |
| 146 | PIM1 | 0.33708036 |
| 147 | CSNK1G2 | 0.33364087 |
| 148 | ILK | 0.32108442 |
| 149 | RPS6KL1 | 0.26690824 |
| 150 | RPS6KC1 | 0.26690824 |
| 151 | FLT3 | 0.24063718 |
| 152 | SCYL2 | 0.23497891 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Lysosome_Homo sapiens_hsa04142 | 3.13012159 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.95566363 |
| 3 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.86682035 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 2.74051625 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.39139184 |
| 6 | Proteasome_Homo sapiens_hsa03050 | 2.35533010 |
| 7 | Leishmaniasis_Homo sapiens_hsa05140 | 2.34315766 |
| 8 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.22468306 |
| 9 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.22002287 |
| 10 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.15065819 |
| 11 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.12451055 |
| 12 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 2.12360417 |
| 13 | Malaria_Homo sapiens_hsa05144 | 1.90407192 |
| 14 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.87757625 |
| 15 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.86696116 |
| 16 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.85005329 |
| 17 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.84744478 |
| 18 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.81682669 |
| 19 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.80098922 |
| 20 | Galactose metabolism_Homo sapiens_hsa00052 | 1.76280477 |
| 21 | Pertussis_Homo sapiens_hsa05133 | 1.74953491 |
| 22 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.69728855 |
| 23 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.69105265 |
| 24 | Tuberculosis_Homo sapiens_hsa05152 | 1.67881850 |
| 25 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.57083376 |
| 26 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.52843415 |
| 27 | Phagosome_Homo sapiens_hsa04145 | 1.46161777 |
| 28 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.42653233 |
| 29 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.40435708 |
| 30 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.39173092 |
| 31 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.39083841 |
| 32 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.37146695 |
| 33 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.36904340 |
| 34 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.34490637 |
| 35 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.34036041 |
| 36 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.33936812 |
| 37 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.33298687 |
| 38 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.32981103 |
| 39 | Measles_Homo sapiens_hsa05162 | 1.32857043 |
| 40 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.30647515 |
| 41 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.29889861 |
| 42 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.29160255 |
| 43 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.26189851 |
| 44 | Salmonella infection_Homo sapiens_hsa05132 | 1.24464205 |
| 45 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.24242336 |
| 46 | Base excision repair_Homo sapiens_hsa03410 | 1.23742560 |
| 47 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.22822273 |
| 48 | DNA replication_Homo sapiens_hsa03030 | 1.22376392 |
| 49 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.20623368 |
| 50 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.19078144 |
| 51 | Allograft rejection_Homo sapiens_hsa05330 | 1.17444090 |
| 52 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.14291926 |
| 53 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.13614206 |
| 54 | Legionellosis_Homo sapiens_hsa05134 | 1.12231857 |
| 55 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.11793805 |
| 56 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.11358853 |
| 57 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.09356068 |
| 58 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.08629968 |
| 59 | Mismatch repair_Homo sapiens_hsa03430 | 1.07913654 |
| 60 | Shigellosis_Homo sapiens_hsa05131 | 1.07408002 |
| 61 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.06800031 |
| 62 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.04284893 |
| 63 | Asthma_Homo sapiens_hsa05310 | 1.04000969 |
| 64 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.02001520 |
| 65 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.00685596 |
| 66 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.00340438 |
| 67 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.00290216 |
| 68 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.99110378 |
| 69 | Endocytosis_Homo sapiens_hsa04144 | 0.98380060 |
| 70 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.95531758 |
| 71 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.94259423 |
| 72 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.91545466 |
| 73 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.88055094 |
| 74 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.87643466 |
| 75 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.84696849 |
| 76 | Carbon metabolism_Homo sapiens_hsa01200 | 0.84494415 |
| 77 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.84469507 |
| 78 | Influenza A_Homo sapiens_hsa05164 | 0.84243059 |
| 79 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.84072098 |
| 80 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.83506939 |
| 81 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.82178443 |
| 82 | Apoptosis_Homo sapiens_hsa04210 | 0.80194072 |
| 83 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.78965586 |
| 84 | Mineral absorption_Homo sapiens_hsa04978 | 0.78826705 |
| 85 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.78566359 |
| 86 | Hepatitis C_Homo sapiens_hsa05160 | 0.78534332 |
| 87 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.78181418 |
| 88 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.75565334 |
| 89 | Hepatitis B_Homo sapiens_hsa05161 | 0.74127145 |
| 90 | Sulfur relay system_Homo sapiens_hsa04122 | 0.73639985 |
| 91 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.73475519 |
| 92 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.72739241 |
| 93 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.71736958 |
| 94 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.70784677 |
| 95 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.68924052 |
| 96 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.68918402 |
| 97 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.68696573 |
| 98 | Platelet activation_Homo sapiens_hsa04611 | 0.68140218 |
| 99 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.66986760 |
| 100 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.64201611 |
| 101 | Viral myocarditis_Homo sapiens_hsa05416 | 0.63291086 |
| 102 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.62230762 |
| 103 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.60103521 |
| 104 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.59985496 |
| 105 | RNA polymerase_Homo sapiens_hsa03020 | 0.59277056 |
| 106 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.59252385 |
| 107 | Prion diseases_Homo sapiens_hsa05020 | 0.58249797 |
| 108 | Amoebiasis_Homo sapiens_hsa05146 | 0.56602015 |
| 109 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.56442578 |
| 110 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.55686492 |
| 111 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.55210074 |
| 112 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.53062229 |
| 113 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.53047000 |
| 114 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.52361280 |
| 115 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.52189918 |
| 116 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.51993579 |
| 117 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.51372080 |
| 118 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.48310510 |
| 119 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.46551109 |
| 120 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.46066791 |
| 121 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.44491890 |
| 122 | Histidine metabolism_Homo sapiens_hsa00340 | 0.43813345 |
| 123 | Prostate cancer_Homo sapiens_hsa05215 | 0.42656917 |
| 124 | Ribosome_Homo sapiens_hsa03010 | 0.42190616 |
| 125 | Axon guidance_Homo sapiens_hsa04360 | 0.41581961 |
| 126 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.41152964 |
| 127 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.40873142 |
| 128 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.40606987 |
| 129 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.38833654 |
| 130 | Parkinsons disease_Homo sapiens_hsa05012 | 0.38619498 |
| 131 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.37327600 |
| 132 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.36574804 |
| 133 | Homologous recombination_Homo sapiens_hsa03440 | 0.36201455 |
| 134 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.36135013 |
| 135 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.35193153 |
| 136 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.34934721 |
| 137 | ABC transporters_Homo sapiens_hsa02010 | 0.34928258 |
| 138 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.34779954 |
| 139 | Metabolic pathways_Homo sapiens_hsa01100 | 0.34482161 |
| 140 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.33889636 |
| 141 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.33515279 |
| 142 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.32523406 |
| 143 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.32445321 |
| 144 | Bladder cancer_Homo sapiens_hsa05219 | 0.31646690 |
| 145 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.28959069 |

